|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.070 USD | +0.25% |
|
+0.74% | +102.49% |
| 06-18 | Chardan Raises Price Target on Opus Genetics to $13 From $11, Keeps Buy Rating | MT |
| 06-16 | Opus Genetics, Inc. - Special Call |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.25% | +0.74% | -5.13% | -7.29% | +102.49% | +328.38% | -1.21% | -17.28% | - | 331M | |
| -1.21% | -3.04% | +5.46% | +21.16% | +2.22% | +44.03% | +142.51% | +393.36% | +1,413.81% | 980B | |
| -2.48% | -5.18% | -1.44% | -2.97% | +10.36% | +52.47% | +39.36% | +39.40% | +96.58% | 550B | |
| -2.14% | -4.94% | +0.93% | +5.57% | -5.25% | +16.83% | +58.18% | +88.70% | +260.94% | 382B | |
| -0.03% | -3.09% | -3.21% | +6.28% | -2.56% | +23.33% | +16.78% | -8.41% | +30.00% | 316B | |
| -0.09% | +0.18% | -4.97% | -3.77% | -4.10% | +26.91% | +14.00% | +58.37% | +240.21% | 272B | |
| +0.25% | -1.26% | -0.64% | +2.22% | +8.30% | +24.84% | +31.80% | +38.36% | +54.46% | 268B | |
| -0.44% | +2.29% | +1.09% | +24.16% | -10.18% | -35.17% | -46.20% | +13.83% | +68.05% | 199B | |
| -1.19% | -4.95% | +0.05% | -2.93% | +3.14% | +16.68% | +48.70% | +40.53% | +125.94% | 182B | |
| -1.35% | -1.46% | -5.16% | -9.80% | +0.83% | +14.06% | +59.46% | +83.76% | +51.31% | 154B | |
| -2.74% | -3.82% | -2.85% | -6.53% | +1.24% | +5.17% | -35.19% | -36.05% | -27.45% | 144B | |
| -1.60% | +1.51% | +4.17% | -0.52% | -0.38% | +2.44% | +31.56% | +140.61% | +429.58% | 115B | |
| -2.32% | -5.48% | -9.32% | -6.05% | +0.11% | +15.24% | -17.56% | -19.20% | -24.21% | 110B | |
| -1.04% | -2.81% | -4.50% | -4.44% | -11.24% | -11.62% | -24.79% | -16.31% | +3.16% | 102B | |
| -0.35% | -1.97% | +0.23% | -0.90% | +5.21% | +36.81% | +41.24% | +10.09% | +8.18% | 101B | |
| -0.37% | +1.27% | -7.02% | -5.35% | -8.75% | +0.16% | +76.41% | +72.13% | +524.23% | 77.05B | |
| +0.83% | -2.22% | -2.62% | -10.79% | +2.90% | +16.13% | +8.41% | +32.60% | +12.76% | 48.34B | |
| +3.04% | -0.14% | -5.89% | -12.19% | -18.72% | -6.45% | +4.35% | -30.34% | +232.97% | 47.32B | |
| -0.32% | +3.61% | -2.31% | -2.20% | +1.65% | +43.40% | -25.50% | -26.67% | -59.04% | 42.64B | |
| -1.12% | -1.55% | -4.04% | -9.76% | -11.98% | -14.09% | +1.51% | - | - | 39.01B | |
| Average | -0.71% | -1.58% | -2.36% | -1.31% | +3.26% | +29.98% | +21.19% | +45.13% | +191.19% | 206.46B | |
| Weighted average by Cap. | -1.14% | -3.15% | -0.19% | +5.17% | +0.63% | +25.46% | +51.75% | +122.29% | +431.54% |
- Stock Market
- Stocks
- IRD Stock
- Sector Opus Genetics, Inc.
Select your edition
All financial news and data tailored to specific country editions
